Some studies on the efficacy of heterologous tetanus antitoxin. 1957

A B VIAL, and W S CALLAHAN

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013742 Tetanus A disease caused by tetanospasmin, a powerful protein toxin produced by CLOSTRIDIUM TETANI. Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia. Localized tetanus presents itself as a mild condition with manifestations restricted to muscles near the wound. It may progress to the generalized form. Clostridium tetani Infection,Clostridium tetani Infections,Infection, Clostridium tetani,Infections, Clostridium tetani
D013743 Tetanus Antitoxin An antitoxin used for the treatment of TETANUS. Antitoxin, Tetanus
D013745 Tetanus Toxoid Tetanus Vaccine,Toxoid, Tetanus,Vaccine, Tetanus

Related Publications

A B VIAL, and W S CALLAHAN
November 1962, American journal of hygiene,
A B VIAL, and W S CALLAHAN
September 1961, The Journal of the Kansas Medical Society,
A B VIAL, and W S CALLAHAN
June 1970, Journal of immunology (Baltimore, Md. : 1950),
A B VIAL, and W S CALLAHAN
August 1967, The Japanese journal of experimental medicine,
A B VIAL, and W S CALLAHAN
February 1984, Biulleten' eksperimental'noi biologii i meditsiny,
A B VIAL, and W S CALLAHAN
April 1964, Dapim refuiim. Folia medica,
A B VIAL, and W S CALLAHAN
July 1911, California state journal of medicine,
A B VIAL, and W S CALLAHAN
January 1968, British medical journal,
A B VIAL, and W S CALLAHAN
February 1964, The Medical journal of Australia,
A B VIAL, and W S CALLAHAN
January 1966, International archives of allergy and applied immunology,
Copied contents to your clipboard!